# PierianDx, Inc.: Form D filings

PierianDx, Inc., a biotechnology company in St. Louis, MO, filed 3 Form D notices with the SEC between 2018 and 2021. The latest, on November 9, 2021, reports $17 million sold of a $17 million offering to 13 investors.

Find out what PierianDx, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20PierianDx%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=PierianDx%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fpieriandx-inc-1730902)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20PierianDx%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=PierianDx%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fpieriandx-inc-1730902)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Missouri](https://specstream.ai/data/form-d/state/missouri): 379 rows, by operating companies, filed since November 1, 2024, $18.95, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/missouri
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 6 Cityplace Drive, Suite 550, St. Louis, MO, 63141
- Phone: (314) 628-0035
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1730902

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 9, 2021 | New notice | $16,983,180 | $16,983,180 | $0 | 13 | Jun 23, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1730902/000173090221000001/0001730902-21-000001-index.htm) |
| Nov 25, 2019 | New notice | $26,870,702 | $21,870,702 | $5,000,000 | 13 | Nov 12, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1730902/000173090219000001/0001730902-19-000001-index.htm) |
| Feb 12, 2018 | New notice | $5,000,000 | $3,046,458 | $1,953,542 | 4 | Jan 29, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1730902/000173090218000001/0001730902-18-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Kerry Propper | Director |  |
| Barnard Buscemi | Director |  |
| Mark McDonough | Executive Officer, Director |  |
| Rakesh Nagarajan | Executive Officer, Director |  |
| Joseph Boorady | Director |  |
| Frederick Hessler | Director |  |
| Bryan Carey | Director |  |

[Every Form D from the week of Nov 8, 2021](https://specstream.ai/data/form-d/week/2021-11-08) · [All recent filings in Missouri](https://specstream.ai/data/form-d/state/missouri) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what PierianDx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).